Status:
COMPLETED
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
Lead Sponsor:
Cairo University
Conditions:
Polycystic Ovary Syndrome
Infertility
Eligibility:
FEMALE
20-40 years
Phase:
EARLY_PHASE1
Brief Summary
Polycystic ovary syndrome (PCOS) affects 5-10% of women in childbearing age. Hyperinsulinemia contributes to chronic anovulation commonly encountered in women with PCOS. The first choice therapy is cl...
Detailed Description
Polycystic ovary syndrome (PCOS) affects 5-10% of women in childbearing age. Hyperinsulinemia contributes to chronic anovulation commonly encountered in women with PCOS. The first choice therapy is cl...
Eligibility Criteria
Inclusion
- 20-40 years old
- PCOS infertile women resistant to CC for3 cycles
Exclusion
- presence of medical disorders as diabetes, hypertension, cardiac problems, liver or kidney diseases, hyperprolactinemia or thyroid dysfunction.
- use of gonadotropins before
- previous ovarian drilling
- presence of urinary symptoms especially bloody urine
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01909141
Start Date
August 1 2013
End Date
April 1 2014
Last Update
October 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt